|
| |||
| Names | |||
|---|---|---|---|
| Preferred IUPAC name
1H-Pyrimidin-6-one | |||
| Other names
Hydroxypyrimidine; Pyrimidinone | |||
| Identifiers | |||
3D model (JSmol) |
|||
| ChemSpider | |||
PubChem CID |
|||
| UNII |
| ||
| |||
| |||
| Properties | |||
| C4H4N2O | |||
| Molar mass | 96.089 g·mol−1 | ||
| Appearance | White to light yellow powder | ||
| Melting point | 163 to 168 °C (325 to 334 °F; 436 to 441 K) | ||
| Hazards | |||
| Occupational safety and health (OHS/OSH): | |||
Main hazards |
Respiratory system, eye, skin irritation | ||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |||
Pyrimidone is the name given to either of two heterocyclic compounds with the formula C4H4N2O: 2-pyrimidone and 4-pyrimidone. The compounds can also be called 2-hydroxypyrimidine or 4-hydroxypyrimidine respectively, based on a substituted pyrimidine, or 1,3-diazine, ring.
Derivatives of pyrimidone are the basis of many other biological molecules, including:
Pyrimidone-derived antiulcer drugs include temelastine, icotidine, donetidine, and lupitidine.
Methylated pyrimidone derivatives undergo pH-switched photoisomerization to the corresponding Dewar arene. The process can be used for long-term thermal energy storage with an energy density of 1.6 MJ/kg, approximately double that of a lithium ion battery.